Secukinumab superior to etanercept for psoriasis

Secukinumab (AIN457), an interleukin-17A (IL-17A) inhibitor, was more effective in treating moderate-to-severe plaque psoriasis than the anti-tumor necrosis factor etanercept and current standard of care, according to a head-to-head phase 3 study. » More

Share »

Joint committee updates criteria for scleroderma

Updated classification criteria for scleroderma should allow for earlier identification and treatment of the autoimmune disease.
» More

Share »

Botulinum toxin injections: Cosmetic & Therapeutic treatment options
Botulinum toxin have a variety of medical uses, including smoothing out frown lines and treating pain. Articles, video, tools, and CME to help you stay up-to-date on the latest medical advances involving neurotoxins. Read More

fyi...

85%

Percentage of physicians who read their online reviews

Source: ZocDoc

Easy-to-use, comprehensive ICD-10 transition toolkit
Endorsed by MGMA and brought to you by Dermatology Times, the Complete Practice Resources ICD-10 Transition Toolkit is a robust and full-featured software solution that will guide you step-by-step and prepare your practice for a successful and well-timed transition. Your satisfaction is guaranteed or your money back. You have nothing to lose but time. Click here to get started today.

Anti-fungal eradicates HIV from infected cells

The topical anti-fungal agent ciclopirox causes HIV-infected cells to commit suicide by jamming up the cells' powerhouse, the mitochondria, according to a recent study. » More

Share »